Correlation Between Adaptive Biotechnologies and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adaptive Biotechnologies and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptive Biotechnologies and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptive Biotechnologies Corp and Intellia Therapeutics, you can compare the effects of market volatilities on Adaptive Biotechnologies and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptive Biotechnologies with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptive Biotechnologies and Intellia Therapeutics.
Diversification Opportunities for Adaptive Biotechnologies and Intellia Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Adaptive and Intellia is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Adaptive Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptive Biotechnologies Corp are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Adaptive Biotechnologies i.e., Adaptive Biotechnologies and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Adaptive Biotechnologies and Intellia Therapeutics
Given the investment horizon of 90 days Adaptive Biotechnologies Corp is expected to generate 1.28 times more return on investment than Intellia Therapeutics. However, Adaptive Biotechnologies is 1.28 times more volatile than Intellia Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 825.00 in Adaptive Biotechnologies Corp on August 30, 2024 and sell it today you would lose (252.00) from holding Adaptive Biotechnologies Corp or give up 30.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptive Biotechnologies Corp vs. Intellia Therapeutics
Performance |
| Timeline |
| Adaptive Biotechnologies |
| Intellia Therapeutics |
Adaptive Biotechnologies and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptive Biotechnologies and Intellia Therapeutics
The main advantage of trading using opposite Adaptive Biotechnologies and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptive Biotechnologies position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |